SI1639013T1 - Pan-kir2dl NK-receptor antibodies and their use in diagnostic and therapy - Google Patents

Pan-kir2dl NK-receptor antibodies and their use in diagnostic and therapy

Info

Publication number: SI1639013T1
Authority: SI; Slovenia
Prior art keywords: kir2dl; pan; diagnostic; therapy; receptor antibodies
Prior art date: 2003-07-02

Application number

SI200431971T

Other languages

Slovenian (sl)

Inventor

Allessandro Moretta

Chiesa Mariella Della

Original Assignee

Innate Pharma

Universita Di Genova

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-07-02

Filing date

2004-07-01

Publication date

2013-01-31

2004-07-01 Application filed by Innate Pharma, Universita Di Genova filed Critical Innate Pharma

2004-07-01 Priority claimed from EP04744115A external-priority patent/EP1639013B1/en

2013-01-31 Publication of SI1639013T1 publication Critical patent/SI1639013T1/en

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US48389403P	2003-07-02	2003-07-02
US54547104P	2004-02-19	2004-02-19
EP04744115A EP1639013B1 (en)	2003-07-02	2004-07-01	Pan-kir2dl NK-receptor antibodies and their use in diagnostic and therapy
PCT/IB2004/002464 WO2005003172A2 (en)	2003-07-02	2004-07-01	Pan-kir2dl nk-receptor antibodies and their use in diagnostik and therapy

Publications (1)

Publication Number	Publication Date
SI1639013T1 true SI1639013T1 (en)	2013-01-31

Family

ID=37031117

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200431971T SI1639013T1 (en)	2003-07-02	2004-07-01	Pan-kir2dl NK-receptor antibodies and their use in diagnostic and therapy

Country Status (4)

Country	Link
CN (2)	CN1852924A (en)
ES (1)	ES2358078T3 (en)
SI (1)	SI1639013T1 (en)
ZA (2)	ZA200600792B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2627923T3 (en) *	2007-01-11	2017-08-01	Novo Nordisk A/S	Anti-KIR antibodies, formulations and uses thereof
WO2010091542A1 (en) *	2009-02-16	2010-08-19	重庆西南医院	Anti-tumor, anti-bacterial and/or anti-viral applications of ctla4ig and derivatives thereof.
CN101804193B (en) *	2009-02-16	2012-09-26	重庆西南医院	CTLA4lg and derivatives thereof used for resisting viruses
WO2012047985A1 (en) *	2010-10-06	2012-04-12	St. Jude Children's Research Hospital	Molecular determinant-based typing of kir alleles and kir-ligands
CN103298831A (en) *	2010-11-22	2013-09-11	伊纳特医药股份有限公司	NK cell modulating therapy and method for treating hematologic malignancies
SG195082A1 (en) *	2011-05-25	2013-12-30	Innate Pharma Sa	Anti-kir antibodies for the treatment of inflammatory disorders
CN104914242B (en) *	2014-09-29	2017-08-11	深圳华大基因科技服务有限公司	For cancer diagnosis and the method and composition for the treatment of

2004
- 2004-07-01 SI SI200431971T patent/SI1639013T1/en unknown
- 2004-07-01 CN CN 200480024006 patent/CN1852924A/en active Pending
- 2004-07-01 ES ES04738967T patent/ES2358078T3/en not_active Expired - Lifetime
- 2004-07-01 CN CN2004800218970A patent/CN1842541B/en not_active Expired - Lifetime
2006
- 2006-01-27 ZA ZA200600792A patent/ZA200600792B/en unknown
- 2006-01-30 ZA ZA200600842A patent/ZA200600842B/en unknown

Also Published As

Publication number	Publication date
ZA200600842B (en)	2007-04-25
CN1852924A (en)	2006-10-25
CN1842541A (en)	2006-10-04
CN1842541B (en)	2013-03-27
ZA200600792B (en)	2007-04-25
ES2358078T3 (en)	2011-05-05

Similar Documents

Publication	Publication Date	Title
PL374586A1 (en)	2005-10-31	Bispecific anti-erb-b antibodies and their use in tumor therapy
PL2287195T3 (en)	2019-10-31	Pan-kir2dl nk-receptor antibodies and their use in diagnostik and therapy
TWI349551B (en)	2011-10-01	Thiophenepyrimidinone derivatives and their use in therapy
IL174994A0 (en)	2006-08-20	Pyrimidin - 4 - yl - 3, 4 - thione compounds and their use in therapy
IL163563A (en)	2011-12-29	Anti-amyloid beta antibodies and their use in medicine
IL190332A0 (en)	2011-08-01	Human antibodies against il13 and therapeutic uses
GB0418542D0 (en)	2004-09-22	Integrated biosensor and simulation system for diagnosis and therapy
EP2014310B8 (en)	2012-12-26	KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
AU2003278807A8 (en)	2004-08-13	KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
IL182652A0 (en)	2007-07-24	Nitrobenzindoles and their use in cancer therapy
IL178012A0 (en)	2006-12-31	Diphenyl-indol-2-on compounds and their use in the treatment of cancer
EP1572741A4 (en)	2006-09-27	Therapeutic and diagnostic agents
AU2003227148A8 (en)	2003-10-27	Anti-ck18 monoclonal antibody and therapeutic and diagnostic uses thereof in cancer
GB0308382D0 (en)	2003-05-21	Therapeutic methods and means
SI1639013T1 (en)	2013-01-31	Pan-kir2dl NK-receptor antibodies and their use in diagnostic and therapy
GB0326578D0 (en)	2003-12-17	Cancer diagnosis and therapy
SG110107A1 (en)	2005-04-28	Compound and use in treatment
AU2003245858A8 (en)	2004-01-23	Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases
GB0318546D0 (en)	2003-09-10	Quinoxalinones and their use
AU2003209459A8 (en)	2003-09-16	Protein-protein interactions in human tumours involving bcmp-7 and bcmp-11
ZA200802541B (en)	2009-10-28	Human antibodies against IL13 and therapeutic uses
GB0424871D0 (en)	2004-12-15	Antibodies and their use in therapy
GB0505908D0 (en)	2005-04-27	Antibodies and their use in therapy
GB0325854D0 (en)	2003-12-10	Pyrazolopyrimidine compounds and their use in medicine
GB0203042D0 (en)	2002-03-27	Anthraquinine compounds their preparation and their use in therapy